WEBINAR 5 - REGISTER NOW!

DetectioN of defective viral genomes as a potential tool to predict respiratory synCytial virus clinical outome
May 27th, 2021 | 16:00 - 17:00 CEST

RSVVW'21 - Save the Date!

​On 10- 12 November 2021 ReSViNET Foundation will host its 6th conference: “RSVVW'21 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions."  This event will take place in Lisbon, Portugal or on a virtual platform depending on the course of the COVID-19 pandemic. Researchers and physicians from all over the world are invited to join the discussions and share their knowledge!  

News

WHEN COVID-19 CASES DECLINE OTHER DISEASES REAPPEAR: RSV OUTBREAK IN SOUTH-EAST QUEENSLAND
​

During the COVID-19 pandemic, other respiratory viruses such as influenza and RSV have decreased, assumingly due to the related public health measurements. However, as social distancing regulations are decreasing, the usual illnesses may reappear in higher rates than before. In south-east ...

Read more​

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

"Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for Vaccines and Immunization (GAVI) ..."

Read more 

meet our scientific team 

The ReSViNET Foundation is the international leading non-profit organization committed to reducing the global burdens of RSV infection.

Paper of the month

- April 2021 - 
Sustainable response to DS-Cav1 in healthy volunteers
The Vaccine Research Center of NIH published a randomized, open-label, dose-escalation phase 1 clinical trial of the DS-Cav1 stabilized pre-F subunit vaccine. 95 healthy adults were...
​
​
Learn more
- March 2021 - 
Outpatient burden of RSV infection in newborns
RSV is the number one cause of hospitalization for acute lower respiratory tract infection in infants. Moreover, RSV affects an even bigger group of non-hospitalized children. Thomas and his ... 
​
​
Learn more
- February 2021 -
Reduction of COVID-19 and related public health measures may inflict a rise in RSV infection
During the current COVID-19 pandemic, RSV infections have fallen of the radar. We have seen a tremendous decrease in RSV infection rates, which usually peak during the fall and winter seasons.  This...
Learn more

Out now: RESVINET T-SHIRTs

Order a ReSViNET T-Shirt and
​contribute to our research.
On 12- 14 November 2019 ReSViNET Foundation heldt its 5th conference: “RSVVW 2019 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions" in Accra, Ghana. ​We look back on a successful, exciting and inspiring meeting. Our special thanks to our sponsors to make this event possible and our chairs and scientific advisory board. Last but not least we thank all the speakers and participants for their contributions. ​

Recent developments in RSV Interventions

Interested in the recent developments of RSV? Then watch the REPLAY here. Prof. Louis Bont and Dr. Natalie Mazur will give a full summary of the highlights of the #RSVVW19 conference in Accra.
​ 

AWARENESS OF RSV AS A GLOBAL HEALTH PROBLEM IS LACKING

To raise and spread awareness, we have launched a ‘RSV Mortality Awareness’ campaign at the start of the RSVVW2019 conference on November 12, by sharing a personal video entitled “Why we should all know about RSV” about Simone van Wyck, a mother who lost her son due to RSV. The RSV awareness video was produced in collaboration with the Bill & Melinda Gates Foundation.

ABOUT RESVINET FOUNDATION

RSV (Respiratory Syncytial Virus) infection is the second most important cause of death during infancy, especially in developing countries. 
Since the inception of ReSViNET network in 2014, we have continuously been working to fulfill our Vision and Mission with the goal to decrease the global burden of RSV infection through the advancement of research; providing scientific input and involvement in clinical trials. ReSViNET Foundation is a financially and otherwise independent regulated entity.
ReSViNET Foundation is certified by NGOsource as equivalent to a U.S. public charity!
We would like to express our sincere condolences to Neeltjes' family for their loss. Jan. 2020.
Neeltje from The Netherlands, 99 years old, participant of the RESCEU Older adults study. RSV is an important cause of pneumonia in older adults. Awareness of RSV in older adults is almost absent. Every year about 3-6% of all older adults are infected with RSV. Course of disease is most severe on older adults with severe underlying disease such as heart failure or COPD.
​

ReSViNET Global partners